Recent Press Releases

ZYTIGA(R) Plus Prednisone Demonstrates Statistically Significant Overall Survival After 49-Month Follow-Up Analysis in Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate Cancer

ZYTIGA(R) Plus Prednisone Demonstrates Statistically Significant Overall Survival After 49-Month Follow-Up Analysis in Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate Cancer...

Release from Jackson Square Partners

IRVINE, Calif., Sept. 27, 2014 -- /PRNewswire/ -- Michael Gallagher, Lead Independent Director Allergan, Inc. 2525 Dupont Drive Irvine, CA 92612 Mr. Gallagher: We have owned Allergan...

Roche purchases shares in tender offer for InterMune, Inc.

BASEL, Switzerland, Sept.

Health Care Equipment Equities under the Scanner - Medtronic, Abbott Laboratories, Stryker, Zeltiq Aesthetics, and EnteroMedics

Editor Note: For more information about this release, please scroll to bottom.

LONDON, September 26, 2014

Abbott Completes Acquisition of CFR Pharmaceuticals; Announces Results of Tender Offer for CFR Shares

Acquisition enhances Abbott's position in Latin America, more than doubling its branded generics pharmaceutical sales and presence in the fast-growing region

ABBOT

Nintedanib* receives positive CHMP opinion for second-line treatment of patients with adenocarcinoma of the lung

Nintedanib* receives positive CHMP opinion for second-line treatment of patients with adenocarcinoma of the lung Nintedanib*, when added to docetaxel, is the first lung cancer treatment to have...

FDA Approves Trulicity™ (dulaglutide), Lilly's Once-Weekly Therapy for Adults with Type 2 Diabetes

FDA Approves Trulicity™ (dulaglutide), Lilly's Once-Weekly Therapy for Adults with Type 2 Diabetes Trulicity, a weekly glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for...

Valeant Provides Update On Third Quarter Results And Sends Letter To Allergan CEO And Lead Independent Director

Valeant Provides Update On Third Quarter Results And Sends Letter To Allergan CEO And Lead Independent Director Overall Same Store Organic Growth (unadjusted for generics) Expected to Exceed 15% in...

Jeffrey W. Ubben, CEO Of ValueAct Capital, Appointed To The Board Of Valeant Pharmaceuticals

Jeffrey W. Ubben, CEO Of ValueAct Capital, Appointed To The Board Of Valeant Pharmaceuticals LAVAL, Quebec, Sept. 25, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX)...

European CHMP Adopts Positive Opinion for Gilead's Harvoni® (Ledipasvir/Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection in Adults

European CHMP Adopts Positive Opinion for Gilead's Harvoni® (Ledipasvir/Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection in Adults FOSTER CITY, Calif., Sep 26, 2014 (BUSINESS WIRE)...

COMUNICADO: CHMP Recommends Approval of Lilly's Ramucirumab (CYRAMZA(TM)) for Advanced Gastric Cancer After Prior Chemotherapy (1)

COMUNICADO: CHMP Recommends Approval of Lilly's Ramucirumab (CYRAMZA(TM)) for Advanced Gastric Cancer After Prior Chemotherapy (1) Positive Opinion Is First Regulatory Action for Ramucirumab in...

Meeting highlights from the Committee for Medicinal Products for Human Use, 22-25 September 2014

Meeting highlights from the Committee for Medicinal Products for Human Use, 22-25 September 2014 Fifteen new medicines and three extensions of indication recommended for approval Fifteen new...

IRESSA RECEIVES CHMP POSITIVE OPINION TO INCLUDE BLOOD BASED DIAGNOSTIC TESTING IN EUROPEAN LABEL

IRESSA RECEIVES CHMP POSITIVE OPINION TO INCLUDE BLOOD BASED DIAGNOSTIC TESTING IN EUROPEAN LABEL 26 September 2014 AstraZeneca today announced that the Committee for Medicinal Products for Human Use...

MOVENTIG® (naloxegol) RECEIVES POSITIVE CHMP OPINION IN THE EU FOR THE TREATMENT OF ADULTS WITH OPIOID-INDUCED CONSTIPATION

MOVENTIG® (naloxegol) RECEIVES POSITIVE CHMP OPINION IN THE EU FOR THE TREATMENT OF ADULTS WITH OPIOID-INDUCED CONSTIPATION Friday, 26 September 2014 AstraZeneca today announced that the...

Novartis drug Signifor® LAR recommended by CHMP for EU approval to treat patients with rare hormonal disorder acromegaly

Novartis drug Signifor® LAR recommended by CHMP for EU approval to treat patients with rare hormonal disorder acromegaly Acromegaly is an endocrine disorder caused by elevated growth hormone (GH)...

Harvoni recommended for the treatment of chronic hepatitis C

Harvoni recommended for the treatment of chronic hepatitis C Growing number of treatment options improve patients' chances of longer and healthier lives The European Medicines Agency has recommended...

Actavis Confirms Generic Butrans® Patent Challenge

Actavis Confirms Generic Butrans® Patent Challenge DUBLIN, Sept. 25, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with...

Almirall's aclidinium bromide/formoterol fumarate recommended for approval in Europe to treat COPD

Almirall's aclidinium bromide/formoterol fumarate recommended for approval in Europe to treat COPD Positive CHMP opinion is an important step in making this new respiratory therapy available to treat...

Indian industry decries smear campaign against its pharma exporters and Government also intrigued

Indian industry decries smear campaign against its pharma exporters and Government also intrigued New Delhi, September 26, 2014: The India Brand Equity Foundation (IBEF), on behalf of the Government...

Roche launches Global Access Program for HIV viral load testing

Roche launches Global Access Program for HIV viral load testing Program expands access to care supporting the Diagnostics Access Iniative PLEASANTON, Calif., Sept. 25, 2014 /PRNewswire/ -- Roche...